The true etiology of the peak in C.M.'s anti-D antibody titer to 1:32, with subsequent conversion to a negative antibody status before delivery, cannot be explained with certainty. On the basis of ...

Eli Lilly is beefing up muscle health R&D, partnering with Juvena Therapeutics in a deal that includes an upfront fee and more than $650 million in milestones.

Waters announced the launch of the BioResolve™ Protein A Affinity Columns with MaxPeak™ Premier Technology, enabling earlier access to results in upstream bioprocessing, faster method ...

Application note 720008780EN: Demonstrates the measurement of antibody titer and aggregate analysis in a single run following a direct-connect ProA-SEC method.

It was not reported how many of these adults had an immune system disease.About 95% of people born before 1957 will have protective antibody titers.

Data from the recently completed 4-week study in diet-induced obese mice show a 26% reduction in fat mass following treatment with the Activin E antibody, with muscle mass fully preserved.

Engineers developed a method to grow artificial muscle tissue that twitches and flexes in multiple, coordinated directions. These tissues could be useful for building 'biohybrid' robots ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using GLP-1 drugs such as Ozempic and Wegovy after losing weight.

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using GLP-1 drugs such as Ozempic and Wegovy after losing weight.

Research shows bimagrumab may prevent muscle and bone loss associated with weight loss medications like Wegovy, offering hope for safer treatment options.

San Diego-based iBio has signed a backloaded agreement with its existing partner AstralBio for a preclinical anti-myostatin antibody that it hopes can induce weight loss while retaining muscle ...

Researchers developed AbMAP, a cutting-edge framework leveraging transfer learning to model antibody hypervariable regions, significantly improving design and immune repertoire analysis.